
	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025

	(in thousands)
Basic earnings per share
Numerator:
Net income (loss)	$	(4,373)	$	914	$	(4,296)	$	(10,938)
Denominator:
Weighted-average common shares outstanding used in computing basic earnings per share	186,087		187,599		187,408		188,213
Basic earnings per share	$	(0.02)	$	0.00	$	(0.02)	$	(0.06)

Diluted earnings per share
Numerator:
Net income (loss)	$	(4,373)	$	914	$	(4,296)	$	(10,938)
Denominator:
Weighted-average shares used in computing basic earnings per share	186,087		187,599		187,408		188,213
Add dilutive impact of employee equity plans	—		821		—		—
Weighted-average shares used in computing diluted earnings per share	186,087		188,420		187,408		188,213
Diluted earnings per share	$	(0.02)	$	0.00	$	(0.02)	$	(0.06)

The dilutive impact of employee equity awards was not applicable to the calculation of diluted net income (loss) per share for the three months ended September 30, 2026 and the nine months ended September 30, 2026 and 2025, as the effect would have been anti-dilutive.

The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of the diluted net income per share attributable to common stockholders for the three months ended September 30, 2025, because their effect would have been anti-dilutive or for which the performance condition had not been met at the end of the period:

The calculation of diluted earnings per share requires us to make certain assumptions related to the use of proceeds that would be received upon the assumed exercise of stock options, purchase of restricted stock or proceeds from the employee stock purchase plan.

On March 11, 2025, our board of directors approved a share repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $75.0 million of our common stock, par value $0.001 per share (the “Common Stock”). The timing and total amount of stock repurchases will depend upon business, economic, and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The Repurchase Program has no expiration date, may be suspended or discontinued at any time without notice, and does not obligate the Company to acquire any specific dollar amount or numbers of shares of Common Stock. On August 26, 2026, our board of directors approved a $50.0 million increase to the Repurchase Program, increasing the total authorization to $125.0 million. Under the Repurchase Program, we repurchased 3,776,155 shares for $30.0 million during the year ended December 31, 2025. We repurchased 10,184,738 shares for $38.7 million during the three months ended September 30, 2026. As of September 30, 2026, $56.3 million remained available for repurchases under the Repurchase Program. See Part II - Item 2. Unregistered Sales of Equity Securities and Use of Proceeds for additional information on the Repurchase Program.